Consumers have taken the helm of health care and are tired of waiting for the industry to change—now, they’re driving that change themselves, according to Deloitte’s “2026 Life Sciences and Health Care (LSHC) Industry Outlook.” Deloitte’s analysis, leveraging the Komodo Healthcare Map™, finds that health systems could lose up to $54.5 billion and biopharma companies as much as $114.1 billion over the next decade if they maintain business as usual and do not seize opportunities to meet growing consumer expectations for convenience, affordability, and trust. The report highlights a potential combined opportunity risk of over $168 billion, as well as a widening gap between what consumers want and how LSHC organizations are responding.
Read the full article: Deloitte 2026 Life Sciences and Health Care Outlook: Industry May Lose Billions in Revenue and Growth if Consumer Mandate Isn’t Met //
Source: https://www.prnewswire.com/news-releases/deloitte-2026-life-sciences-and-health-care-outlook-industry-may-lose-billions-in-revenue-and-growth-if-consumer-mandate-isnt-met-302618182.html